Whole exome sequencing detects variants of genes that mediate response to anticancer drugs-Reference-Cited by-同舟云学术

Whole exome sequencing detects variants of genes that mediate response to anticancer drugs

Published:2017 Issue:2 Volume:42 Page:137-144
ISSN:0388-1350
Container-title:The Journal of Toxicological Sciences
language:en
Short-container-title:J. Toxicol. Sci.

Author:

Ohnami Sumiko¹,Nagashima Takeshi¹²,Urakami Kenichi¹,Shimoda Yuji¹²,Kamada Fukumi¹,Saito Junko³,Naruoka Akane³,Serizawa Masakuni³,Masuda Yoko⁴,Ohnami Shumpei¹,Kusuhara Masatoshi³⁴,Yamaguchi Ken⁵⁶

Affiliation:

1. Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute

2. SRL Inc.

3. Drug Discovery and Development Division, Shizuoka Cancer Center Research Institute

4. Regional Resources Division, Shizuoka Cancer Center Research Institute

5. Shizuoka Cancer Center Hospital

6. Shizuoka Cancer Center Research Institute

Publisher

Japanese Society of Toxicology

Subject

Toxicology

Link

https://www.jstage.jst.go.jp/article/jts/42/2/42_137/_pdf

Reference34 articles.

1. Bell, G.C., Donovan, K.A. and McLeod, H.L. (2015): Clinical implications of opioid pharmacogenomics in patients with cancer. Cancer Control, 22, 426-432.

2. Boland, J.F., Chung, C.C., Roberson, D., Mitchell, J., Zhang, X., Im, K.M., He, J., Chanock, S.J., Yeager, M. and Dean, M. (2013): The new sequencer on the block: comparison of Life Technology’s Proton sequencer to an Illumina HiSeq for whole-exome sequencing. Hum. Genet., 132, 1153-1163.

3. Chen, Y. and Goldstein, J.A. (2009): The transcriptional regulation of the human CYP2C genes. Curr. Drug Metab., 10, 567-578.

4. Cheng, L., Li, M., Hu, J., Ren, W., Xie, L., Sun, Z.P., Liu, B.R., Xu, G.X., Dong, X.L. and Qian, X.P. (2014): UGT1A1*6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians. Cancer Chemother. Pharmacol., 73, 551-560.

5. Chouchana, L., Narjoz, C., Roche, D., Golmard, J.L., Pineau, B., Chatellier, G., Beaune, P. and Loriot, M.A. (2014): Interindividual variability in TPMT enzyme activity: 10 years of experience with thiopurine pharmacogenetics and therapeutic drug monitoring. Pharmacogenomics, 15, 745-757.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes;Scientific Reports;2022-10-26

2. Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug- metabolizing enzyme genes;2022-08-10

3. Influence of genetic variants of opioid-related genes on opioid-induced adverse effects in patients with lung cancer;Medicine;2021-11-05

4. Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing;Saudi Journal of Biological Sciences;2021-01